Statements of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net loss	$ (4,995,376)	$ (3,300,795)
Adjustments to reconcile net loss to net cash provided by operating activities
Depreciation	343,218	258,119
Gain on disposal of property and equipment	0	(4,400)
Stock-based compensation expense	511,457	229,679
Stock issued for services	0	210,000
Amortization of deferred financing costs	0	13,022
Lease incentives received from landlord, net of amortization of deferred rent related to lease incentives	(126,999)	(37,704)
Accretion and amortization on available for sale investments	90,125	98,006
Change in operating assets and liabilities
(Increase) Decrease in Accounts receivable, trade	(27,666)	107,693
Inventories	(869,411)	(544,300)
Prepaid expenses and other current assets	15,192	(23,123)
Increase (Decrease) in
Accounts payable	194,386	(392,408)
Accrued compensation and other current liabilities	(145,419)	7,078
Accrued interest, related parties	0	177,308
Deferred rent	36,632	39,509
Net cash used in operating activities	(4,973,861)	(3,162,316)
Cash flows from investing activities
Purchase of available-for-sale investments	(1,409,695)	(7,952,119)
Sales/maturities of available-for-sale investments	7,067,000	402,376
Cash received from sale of property and equipment	0	4,400
Costs associated with internal use software development	(1,283,685)	0
Purchase of property and equipment	(134,012)	(589,680)
Net cash provided by (used in) investing activities	4,239,608	(8,135,023)
Cash flows from financing activity
Proceeds from exercise of common stock options and warrants	368,753	83,594
Proceeds from sale of common stock, net of expenses	0	13,596,230
Net cash provided by financing activity	368,753	13,679,824
Net increase (decrease) in cash and cash equivalents	(365,500)	2,382,485
Cash and cash equivalents - beginning of period	2,538,758	156,273
Cash and cash equivalents - end of period	2,173,258	2,538,758
Non-cash financing activities
Acquisition of intangible asset from non-controlling interest (See Note 1)	0	2,215,385
Conversion of notes payable and related party accrued interest to equity, net of unamortized deferred finance costs (See Note 1)	0	14,180,193
Costs incurred for capitalized internal use software not paid as of year-end (amounts are included in liabilities)	415,050	0
Proceeds from issuance of common stock on exercise of common stock options not received as of year-end	$ 32,223	$ 0